Shopping Cart 0
Cart Subtotal
USD 0

Macrogen Inc (038290) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 125

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 250

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 375
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Macrogen Inc (038290)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Macrogen Inc (Macrogen) is a provider of customized services for developing transgenic mouse models. The company's service offerings include DNA sequencing, oligonucleotide synthesis, next generation sequencing, microarray analysis, DNA chip, genetically engineered mice services, bioinformatics services, and project support. Macrogen conducts research for government agencies, universities, and research institutes; clinical diagnostic for patients and medical personnel; studies individual genomics for general public; studies genetics of law; and other related fields. It also invests in Clinical diagnostics and personal genomics which includes the examination of cancer genome, rare disease genome, prenatal genome and individual genome, and also focuses on suggesting personalized diagnosis, treatment, and health care methods. Macrogen is headquartered in Seoul, South Korea.

Macrogen Inc Key Recent Developments

Aug 20,2018: SK Telecom ties up with biotech firm to develop AI genome analysis solutions

Aug 13,2018: Macrogen receives CAP accreditation in two clinical laboratories in Korea

Jun 04,2018: Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest

Sep 04,2017: Macrogen Established Its Branch in Spain, Strengthening Localization Service in Europe

Jun 02,2017: Macrogen Launches Special Promotion on Exome Sequencing to Celebrate Their 20th Anniversary

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Macrogen Inc-Key Facts 6

Macrogen Inc-Key Employees 7

Macrogen Inc-Key Employee Biographies 8

Macrogen Inc-Major Products and Services 9

Macrogen Inc-History 10

Macrogen Inc-Company Statement 13

Macrogen Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Macrogen Inc-Business Description 16

Business Segment: DNA Sequencing 16

Overview 16

Performance 16

Business Segment: Genetically Engineered Mouse (GEM) 16

Overview 16

Performance 16

Business Segment: Micoarray 16

Overview 16

Performance 16

Business Segment: Oligo 16

Overview 16

Performance 17

Geographical Segment: Australia 17

Performance 17

Geographical Segment: Canada 17

Performance 17

Geographical Segment: EU 17

Performance 17

Geographical Segment: Japan 17

Performance 17

Geographical Segment: Korea 17

Performance 17

Geographical Segment: US 17

Performance 17

Macrogen Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

Macrogen Inc-Strengths 18

Macrogen Inc-Weaknesses 19

Macrogen Inc-Opportunities 20

Macrogen Inc-Threats 21

Macrogen Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 27

Financial Performance 27

Financial Ratios-Interim Ratios 28

Financial Ratios-Ratio Charts 29

Section 4-Company's Lifesciences Financial Deals and Alliances 30

Macrogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Macrogen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Macrogen Inc, Recent Deals Summary 32

Section 5-Company's Recent Developments 33

Aug 13, 2018: Macrogen receives CAP accreditation in two clinical laboratories in Korea 33

Jun 04, 2018: Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest 34

Sep 04, 2017: Macrogen Established Its Branch in Spain, Strengthening Localization Service in Europe 35

Jun 02, 2017: Macrogen Launches Special Promotion on Exome Sequencing to Celebrate Their 20th Anniversary 36

Mar 28, 2017: Macrogen Leads Precision Medicine by Advancing the Realization of the "USD 100 Genome Age" 37

Mar 28, 2017: Macrogen Leads Precision Medicine by Advancing the Realization of the "USD 100 Genome Age" 38

Section 6-Appendix 39

Methodology 39

Ratio Definitions 39

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Macrogen Inc, Performance Chart (2013-2017) 27

Macrogen Inc, Ratio Charts 29

Macrogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Macrogen Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 31


List Of Table

List of Tables

Macrogen Inc, Key Facts 6

Macrogen Inc, Key Employees 7

Macrogen Inc, Key Employee Biographies 8

Macrogen Inc, Major Products and Services 9

Macrogen Inc, History 10

Macrogen Inc, Other Locations 14

Macrogen Inc, Key Competitors 22

Macrogen Inc, Ratios based on current share price 23

Macrogen Inc, Annual Ratios 24

Macrogen Inc, Annual Ratios (Cont...1) 25

Macrogen Inc, Annual Ratios (Cont...2) 26

Macrogen Inc, Interim Ratios 28

Macrogen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 30

Macrogen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 31

Macrogen Inc, Recent Deals Summary 32

Currency Codes 39

Capital Market Ratios 39

Equity Ratios 40

Profitability Ratios 40

Cost Ratios 41

Liquidity Ratios 41

Leverage Ratios 42

Efficiency Ratios 42

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Macrogen Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

SeouLin Bioscience Co Ltd

Integrated DNA Technologies Inc

Cofactor Genomics Inc

Bioneer Corp

Ambry Genetics Corp